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Neurological disorders with a genetic basis usually involve the degeneration of distinct cellular subpopulations within the central nervous system (CNS). The factors shaping the differential sensitivity of neurons to the same genetic insult are poorly understood. Sensitivity to disease may be cell autonomous, with the particular molecular makeup of one subpopulation of neurons being responsible for the phenotype. In an alternative scenario that has received much less attention so far, a subpopulation of neurons might be prone to degeneration due to alterations in the function of the neuronal circuits that impinge onto those neurons. In the latter view, degenerating neurons might represent the ''weakest link'' within a circuit, although they are not primarily affected by the genetic mutation. The circuit scenario further implies that distinct dysfunction pathways affecting the same circuit might produce comparable patterns of neurodegeneration. In this issue of Cell, Imlach et al. (2012) and Lotti et al. (2012) provide evidence in a Drosophila model of spinal muscular atrophy (SMA) that motoneuron dysfunction is in fact due to impairments in the function of sensory neurons and interneurons ( Figure 1 ).
SMA is a frequent autosomal-recessive motoneuron disorder characterized by the degeneration of a motoneurons due to inactivation of the survival of motor neuron 1 (SMN1) gene. SMN1 protein is critically involved in the biogenesis of small nuclear ribonucleoproteins (snRNPs), and SMN1 loss extensively affects RNA splicing. Complete loss of SMN1 is lethal, but in most tissues, small amounts of SMN2 protein are sufficient to ensure proper function, and only motoneurons appear to degenerate in SMA.
Motoneurons have thus appeared to be plausible candidates for cell-autonomous neurodegeneration. Their large cell bodies, extremely long axons, and large neuromuscular junctions (NMJs) impose high metabolic and trafficking demands, which might provide sensitive targets for genetic mutations. In SMA mice, deletion of SMN1 causes moderate loss of motoneurons but profound motor impairments and lethality at 2 weeks of age; reexpression of SMN1 throughout the CNS prevents motoneuron degeneration (Gavrilina et al., 2008) . However, restoration of SMN1 levels specifically in motoneurons does not effectively rescue the SMA phenotype; although synaptic abnormalities at the NMJ are rescued, survival is only extended by a few days (Martinez et al., 2012; Gogliotti et al., 2012) . Along similar lines, loss of SMN1 restricted to motoneurons only produces a partial SMA-like phenotype (Park et al., 2010) . These findings have suggested that SMN1 depletion in cells other than motoneurons might have an important role in the pathogenesis of SMA. Imlach et al. (2012) now study these questions in a Drosophila model in which the SMN1 ortholog SMN is deleted ubiquitously. Mutant flies exhibited motoneuron hyperexcitability, altered rhythmic motor activity, and muscular atrophy at larval stage. Panneuronal restoration of SMN fully rescues these phenotypes. Surprisingly, re-expression of SMN in motoneurons, in all glutamatergic neurons, or in inhibitory neurons entirely fails to attenuate the phenotype of mutant flies. In contrast, re-expression of SMN in cholinergic neurons fully rescues all mutant phenotypes. SMN rescue in bipolar dendrite (bd) and type I multidendritic (md) sensory (cholinergic) neurons normalizes muscle size and NMJ neurotransmission, whereas full rescue of locomotion requires re-expression of SMN in additional cholinergic subpopulations. SMN deletion in cholinergic neurons causes an SMN-related phenotype by reducing the excitability of these neurons. Thus, depressing the activity of cholinergic neurons fully reproduces the phenotypic consequences of SMN deletion, and increasing cholinergic neuron excitation by genetic or pharmacological approaches is sufficient to rescue all SMN-related phenotypes. SMN depletion therefore primarily affects the function of a subpopulation of cholinergic sensory and spinal interneurons, whose decreased excitatory drive causes motoneuron dysfunction.
In the companion study, Lotti et al. (2012) investigate the molecular consequences of reduced SMN protein in Drosophila. Building on the preferential reduction in the minor snRNP class reported for SMA mice, Lotti et al. (2012) first show that SMN depletion dramatically impairs U12 splicing in vitro and then use the Drosophila model to identify relevant target genes aided by the fact that there are only 23 putative U12 introns. Eighteen out of 23 introns exhibit aberrant splicing, and seven out 18 tested candidate genes exhibit reduced mature messenger RNA (mRNA) levels. Knockdown of one of them (Stasimon), but not of any of the other genes, causes an NMJ phenotype closely resembling loss of SMN. Stasimon knockdown in motoneurons does not affect NMJ function, whereas its knockdown in cholinergic neurons reproduces SMN-related phenotypes. Likewise, re-expressing Stasimon in SMN mutant motoneurons does not affect the SMN phenotype, whereas reexpression of Stasimon in cholinergic neurons fully restores NMJ activity and muscle size. Overall, locomotor and motor rhythms are not rescued, suggesting that further defects upon SMN depletion in cholinergic neurons account for the residual phenotypes. Lotti et al. (2012) further provide evidence that Stasimon splicing is severely affected in motoneurons and dorsal root ganglia neurons in a mouse model of SMA. Stasimon expression also rescues motor axon disruptions observed upon SMN knockdown in zebrafish. Although the function of Stasimon is currently unknown, it is highly conserved and related to Golgi SNARE proteins, suggesting that it might be involved in intracellular trafficking.
Taken together, these two studies suggest that splicing alterations in Drosophila Stasimon within restricted subpopulations of cholinergic neurons suppresses the excitation of these neurons, which in turn leads to motoneuron dysfunction. In findings reminiscent of these circuit dysfunction results in Drosophila, monosynaptic connections between proprioceptive (sensory) neurons and motoneurons are severely affected and then lost in SMA mice (Mentis et al., 2011) . The upshot of these new discoveries is that the degeneration of motoneurons in SMA might not be a cell-autonomous consequence of SMN loss but is instead the outcome of a network dysfunction in which motoneurons are particularly sensitive to diminished excitation. Whether motoneuron degeneration results from a deficit in excitation or from a homeostatic increase in excitability remains to be determined. Although circuit contributions provide the main mechanism leading to motoneuron dysfunction in Drosophila larvae lacking SMN, in SMA mice, marked rescue has been reported by SMN1 re-expression in motoneurons only or in peripheral tissue (Gogliotti et al., 2012; Martinez et al., 2012; Hua et al., 2011) . Possible interactions between circuit-based mechanisms and either cell-autonomous or systemic effects of SMN1 deletion deserve further investigation. Alternatively, loss of SMN might primarily affect cholinergic neuron function. Thus, whereas mammalian motoneurons (and a few spinal interneuron subpopulations) are cholinergic, motoneurons are glutamatergic in Drosophila. Conversely, the sensory and spinal interneurons affected by the absence of SMN in flies are cholinergic. Accordingly, Stasimon deficits might affect the function of distinct cholinergic neuron subpopulations but produce comparable circuit-level disruptions and motoneuron degeneration in vertebrates and flies.
Circuit mechanisms may also be relevant to other neurodegenerative diseases. In Huntington disease, the degeneration of medium spiny neurons is greatly accelerated by a dearth of cortex-derived BDNF (Milnerwood and Raymond, 2010) . In Alzheimer disease, network dysfunction may be the earliest mechanism accounting for cognitive impairment (Verret et al., 2012) . The notion that the distinct neuronal sensitivities might result from circuit-level dysfunctions indirectly affecting those more vulnerable neurons (along with cell-autonomous features) may thus provide a general conceptual framework to elucidate mechanisms of disease in neurodegeneration.
